Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Yuji MUKAI"'
Publikováno v:
Therapeutic Drug Monitoring. 44:762-770
Dried blood spots (DBSs) are promising candidates for therapeutic drug monitoring. In this study, a simple method for the simultaneous measurement of tyrosine kinase inhibitors (TKIs), including bosutinib, dasatinib, ibrutinib, imatinib, nilotinib, a
Autor:
Tae Hatsuyama, Takaki Toda, Azusa Wakamoto, Yuji Mukai, Hideki Sato, Tatsunari Yoshida, Akihisa Fujita, Nobuo Inotsume
Publikováno v:
Therapeutic Drug Monitoring. 43:772-779
Background Routine therapeutic drug monitoring is a promising approach for the rational use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and anaplastic lymphoma kinase (ALK) inhibitors. The purpose of this study was to d
Autor:
Yuji MUKAI, Hongzhi BAI
Publikováno v:
Journal of The Surface Finishing Society of Japan. 73:304-306
Autor:
Yuka Kato, Asuna Senda, Yuji Mukai, Miki Yamashita, Yuki Sasaoka, Minayo Hanada, Fuminori Hongo, Mitsugu Hirokami, Anders Rane, Nobuo Inotsume, Takaki Toda
Publikováno v:
European Journal of Clinical Pharmacology
Purpose Several clinical studies have demonstrated that angiotensin-converting enzyme inhibitors, but not angiotensin II receptor blockers (ARBs), reduce the risk of non-fatal myocardial infarction and cardiovascular mortality. We found that ARBs inh
Publikováno v:
Therapeutic drug monitoring. 43(3)
Background Recent reports highlight the importance of therapeutic drug monitoring (TDM) of BCR-ABL and Bruton's tyrosine kinase inhibitors (TKIs); thus, large-scale studies are needed to determine the target concentrations of these drugs. TDM using d
Autor:
Mayuko Soma, Yuji Mukai, Takaki Toda, Nobuo Inotsume, Takashi Mishima, Hiroshi Yoshida, Ainari Konda, Mitsuaki Keira, Yoichi Sasaki
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO1-11
Publikováno v:
Xenobiotica. 48:898-903
1. Epoxyeicosatrienoic acids (EETs), metabolites of arachidonic acid (AA) via cytochrome P450s, have a protective effect on the cardiovascular system involving vasodilation. We have previously demonstrated that telmisartan (TEL) inhibits EETs product
Publikováno v:
Biological & Pharmaceutical Bulletin. 40:1409-1415
Epoxyeicosatorienoic acids (EETs) are generated from arachidonic acid (AA) by CYPs. EETs comprise four regioisomers (14,15-, 11,12-, 8,9-, and 5,6-EET). EETs show potent physiological effects, including vasodilation, anti-inflammation, myocardial pre
Autor:
Hiroshi Yoshida, Yuji Mukai, Satoko Fujieda, Yoichi Sasaki, Mayuko Soma, Nobuo Inotsume, Ainari Konda, Mitsuaki Keira, Takaki Toda
Publikováno v:
Biological & Pharmaceutical Bulletin. 40:922-925
Ritodrine, a drug for the treatment of threatened premature labor, is a highly selective beta-2 agonist with the major metabolites of sulfate and glucuronide conjugates. This study investigated the continuous evaluation of the concentration of ritodr
Autor:
Yuji Mukai, Hiroshi Yoshida, Mayuko Soma, Takaki Toda, Satoko Fujieda, Ainari Konda, Nobuo Inotsume, Mitsuaki Keira, Yoichi Sasaki
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 48:91-94